AtriCure, Inc. ATRC
$44.30
+1.86%
at last close
Analyst Consensus
- Consensus Rating
- Buy (6 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $50.67
- Implied Upside
- +14.4%
- Price Target Range
- $45.00 – $55.00
- Analysts (12 mo)
- 7
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-07-28 | UBSPriya Sachdeva |
Maintains | Buy | $55 → $50 |
| 2026-05-06 | Canaccord GenuityWilliam Plovanic |
Maintains | Buy | $53 → $55 |
| 2026-02-18 | Canaccord GenuityWilliam Plovanic |
Maintains | Buy | $64 → $53 |
| 2026-02-18 | UBSDanielle Antalffy |
Maintains | Buy | $60 → $55 |
| 2026-02-18 | CitizensDaniel Stauder |
Maintains | Market outperform | $60 → $52 |
| 2026-02-18 | OppenheimerSuraj Kalia |
Downgrades | Outperform → Perform | — |
| 2026-02-18 | BTIGMarie Thibault |
Reiterates | Buy | $54 |
| 2026-02-12 | NeedhamMike Matson |
Reiterates | Buy | $45 |
| 2025-12-16 | JP MorganLilia-Celine Lozada |
Maintains | Overweight | $42 → $48 |
| 2025-10-30 | Canaccord GenuityWilliam Plovanic |
Maintains | Buy | $53 → $64 |
| 2025-07-30 | NeedhamMike Matson |
Maintains | Buy | $44 → $45 |
| 2025-04-30 | UBSDanielle Antalffy |
Maintains | Buy | $60 → $58 |
| 2025-04-30 | JMP SecuritiesDaniel Stauder |
Reiterates | Market outperform | $60 |
| 2025-04-30 | NeedhamMike Matson |
Maintains | Buy | $51 → $44 |
| 2025-04-02 | Citizens Capital MarketsDaniel Stauder |
Reiterates | Market outperform | $60 |
| 2025-03-28 | Canaccord GenuityWilliam Plovanic |
Maintains | Buy | $66 → $52 |
| 2025-03-27 | JP MorganLilia-Celine Lozada |
Maintains | Overweight | $51 → $46 |
| 2025-03-27 | NeedhamMike Matson |
Reiterates | Buy | $51 |
| 2025-03-21 | NeedhamMike Matson |
Reiterates | Buy | $51 |
| 2025-02-13 | OppenheimerSuraj Kalia |
Maintains | Outperform | $36 → $45 |
| 2025-02-13 | Piper SandlerMatt O'Brien |
Maintains | Overweight | $40 → $50 |
| 2025-02-13 | JMP SecuritiesDaniel Stauder |
Reiterates | Market outperform | $60 |
| 2025-02-13 | StifelRick Wise |
Maintains | Buy | $36 → $48 |
| 2025-02-13 | NeedhamMike Matson |
Reiterates | Buy | $51 |
| 2025-02-13 | Canaccord GenuityWilliam Plovanic |
Maintains | Buy | $61 → $66 |
| 2025-02-11 | JP MorganLilia-Celine Lozada |
Maintains | Overweight | $40 → $51 |
| 2025-02-10 | JMP SecuritiesDaniel Stauder |
Reiterates | Market outperform | $60 |
| 2025-01-22 | NeedhamMike Matson |
Maintains | Buy | $40 → $51 |
| 2025-01-13 | NeedhamMike Matson |
Reiterates | Buy | $40 |
| 2024-12-17 | JP MorganLilia-Celine Lozada |
Assumes | Overweight | $40 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $44.30
- Market Cap
- $2.22 billion
- 52-Week Range
- $25.36 – $44.48
- Average Volume
- 839K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.